Cao, Z., Liang, N., Yang, H., & Li, S. (2017). Visfatin mediates doxorubicin resistance in human non–small‐cell lung cancer via Akt‐mediated up‐regulation of ABCC1. Cell Prolif.
Style de citation ChicagoCao, Zhili, Naixin Liang, Huaxia Yang, et Shanqing Li. "Visfatin Mediates Doxorubicin Resistance in Human Non–small‐cell Lung Cancer Via Akt‐mediated Up‐regulation of ABCC1." Cell Prolif 2017.
Style de citation MLACao, Zhili, Naixin Liang, Huaxia Yang, et Shanqing Li. "Visfatin Mediates Doxorubicin Resistance in Human Non–small‐cell Lung Cancer Via Akt‐mediated Up‐regulation of ABCC1." Cell Prolif 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.